Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703818 · ClinicalTrials.gov registry record · NA
SCS for the Treatment Of Chronic Pain of the Upper Extremities
A NA study of Upper Extremity Pain, sponsored by Nevro.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT02703818 is a NA study of Upper Extremity Pain that has completed, run by Nevro. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02703818, a NA study of Upper Extremity Pain, has completed, sponsored by Nevro.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.
Conditions Studied
Interventions
- DEVICE Senza
Study Locations (1)
California
- NEVRO Corp - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703818
The ClinicalTrials.gov registry entry for NCT02703818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevro, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Extremity Pain appearing as the primary indexed condition, and to 1 intervention - of which Senza is the first listed.
NCT02703818 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02703818 about?
NCT02703818 is a clinical study titled "SCS for the Treatment Of Chronic Pain of the Upper Extremities". This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.
What is the current status of trial NCT02703818?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-02. Estimated completion is 2018-05.
What conditions does trial NCT02703818 study?
This clinical trial studies the following conditions: Upper Extremity Pain.
What interventions are being tested in trial NCT02703818?
The interventions under investigation include: Senza (DEVICE).
Who is sponsoring clinical trial NCT02703818?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703818 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Extremity Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.